Niagen Bioscience Inc. held its Annual Meeting of Stockholders on June 24, 2025. During the meeting, several proposals were presented and approved. The amendment to the 2017 Equity Incentive Plan, which increases the number of shares available for issuance by 4.75 million shares of common stock, was approved. The Employee Stock Purchase Plan, allowing officers and employees to purchase shares at a discount, was also approved. Additionally, the election of directors was confirmed, with all nominated directors elected to serve.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.